Fred Alger Management’s Redhill Biopharma RDHL Stock Holding History

Fred Alger Management’s Portfolio RDHL Stock Details RDHL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-22	Closed	-$299K	–	515
2016 Q3	$299K	Buy	22 +6	+38%	+$83.9K	﹤0.01%	368
2016 Q2	$169K	Hold	16	–	–	﹤0.01%	416
2016 Q1	$190K	Sell	16 -17	-52%	-$178K	﹤0.01%	444
2015 Q4	$425K	Sell	33 -8	-20%	-$99.5K	﹤0.01%	444
2015 Q3	$529K	Buy	41 +6	+17%	+$88.8K	﹤0.01%	429
2015 Q2	$610K	Buy	+35	New	+$556K	﹤0.01%	456

Other funds holding RDHL

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

MMH

Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return

MIFH

Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

BHB

Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Nexthera Capital New York $120M AUM 10.01% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

Fred Alger Management's RDHL Position: Q4 2016 in Review

Fred Alger Management sold out of Redhill Biopharma (RDHL) in Q4 2016, closing a stake of 22 shares — an estimated $299K sold.

Fred Alger Management first reported a position in RDHL in Q2 2015 and held it in 6 quarters. The position peaked at $610K in Q2 2015. 22 funds tracked by Wall St. Rank hold RDHL as of Q4 2016.

Fred Alger Management reported no remaining Redhill Biopharma position as of Q4 2016 after selling out during the quarter.
Fred Alger Management sold 22 Redhill Biopharma shares in Q4 2016, an estimated $299K.
Fred Alger Management first reported a position in Redhill Biopharma in Q2 2015 and held it in 6 quarters.
Fred Alger Management's Redhill Biopharma position peaked at $610K in Q2 2015.
22 funds tracked by Wall St. Rank held Redhill Biopharma as of Q4 2016.

Based on Fred Alger Management's 13F filing for Q4 2016, filed 14 Feb 2017.